Preemptive total gastrectomy for hereditary gastric cancer

Journal of Gastrointestinal Surgery

Volumn 11, Issue 3, 2007, Pages 314-317

  Medina Franco, Heriberto ^a   Barreto Zuñiga, Rafael ^a   García Alvarez, Miriam N ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

E cadherin mutation; Hereditary gastric cancer; Prophylactic gastrectomy

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CASE REPORT; GASTRECTOMY; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; PEDIGREE; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; GASTRECTOMY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEDIGREE; STOMACH NEOPLASMS;

EID: 34247627943     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0122-2     Document Type: Article

References (17)

1. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-405.
2. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-1027.
3. Aarnio M, Salovaara R, Aaltonen LA, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997;74:551-555.
4. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873-880.
5. Medina-Franco H, Heslin MJ, Cortés-González R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000;7:515-519.
6. Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005;54:461-468.
7. Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic gastrectomy indicated? Cancer 2001;92:181-187.
8. Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Eng J Med 2001;344:1904-1909.
9. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics 2001. CA Cancer J Clin 2001;51:15-36.
10. La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-55.
11. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249-255.
12. Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177-180.
13. Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005;11:5401-5409.
14. Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast Reattachedcancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348-1353.
15. Humar B, Graziano F, Cascinu S, et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002;21:8192-8195.
16. Park WS, Cho YG, Park JY, et al. A single nucleotide polymorphism in the E-cadherin gene promoter -160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003;18:501-504.
17. Medina-Franco H, Contreras-Saldívar A, Ramos-De la Medina A, et al. Surgery for stage IV gastric cancer. Am J Surg 2004;187:543-546.